MyoKardia is a biopharmaceutical company that develops and commercializes therapies for the treatment of cardiovascular diseases. MyoKardia was founded in 2012. MyoKardia's headquarters is located in Brisbane, California, USA 94005.
MyoKardia's CEO, ... MyoKardia's CEO, Tassos Gianakakos, currently has an approval
rating of 94%. MyoKardia's primary competitors are Tenaya, Cytokinetics, Five Prime and 17 more.
There have been no acquisitions found related to MyoKardia
Recent investment data cannot be found related to MyoKardia